Disclosures for Rohan Khera, MD, MS

Last updated - Oct 1, 2022

Funding:

  • NHLBI – K23HL153775

  • Doris Duke Charitable Foundation CSDA

  • Bristol Myers Squibb through Yale

Disclosures:

  • Dr. Khera is the listed inventor on the following patents:

    • U.S. Pending Patent Application No. 63/177,117, “Methods for neighborhood phenomapping for clinical trials”

    • U.S. Provisional Patent Application No. 63/346,610, “Articles and methods for format-independent detection of hidden cardiovascular disease from printed electrocardiographic images using deep learning”

  • Dr. Khera is the co-founder of Evidence2Health, a precision health analytics platform

  • Unless explicitly stated, any algorithms discussed in the presentation are for research use and are not approved for clinical use.